{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:08:26Z","timestamp":1790863706362,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The t(8;21) RUNX1-ETO translocation is one of the most frequent cytogenetic abnormalities in acute myeloid leukemia (AML). In RUNX1-ETO+ patient samples, differing classes of activating c-KIT receptor tyrosine kinase mutations have been observed. The most common (12%-48%) involves mutations, such as D816V, which occur in the tyrosine kinase domain, whereas another involves mutations within exon 8 in a region mediating receptor dimerization (2%-13% of cases). To test whether distinct subtypes of activating c-KIT mutations differ in their leukemogenic potential in association with RUNX1-ETO, we used a retroviral transduction\/transplantation model to coexpress RUNX1-ETO with either c-KitD814V or c-KitT417I\u0394418-419 in murine hematopoietic stem\/progenitor cells used to reconstitute lethally irradiated mice. Analysis of reconstituted animals showed that RUNX1-ETO;c-KitD814V coexpression resulted in 3 nonoverlapping phenotypes. In 45% of animals, a transplantable AML of relatively short latency and frequent granulocytic sarcoma was noted. Other mice exhibited a rapidly fatal myeloproliferative phenotype (35%) or a lethal, short-latency pre-B-cell leukemia (20%). In contrast, RUNX1-ETO;c-KitT417I\u0394418-419 coexpression promoted exclusively AML in a fraction (51%) of reconstituted mice. These observations indicate that c-KitD814V promotes a more varied and aggressive leukemic phenotype than c-KitT417I\u0394418-419, which may be the result of differing potencies of the activating c-Kit alleles.<\/jats:p>","DOI":"10.1182\/blood-2011-02-338228","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T04:58:32Z","timestamp":1316667512000},"page":"1522-1531","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["Distinct classes of c-Kit\u2013activating mutations differ in their ability to promote RUNX1-ETO\u2013associated acute myeloid leukemia"],"prefix":"10.1182","volume":"119","author":[{"given":"Heidi J.","family":"Nick","sequence":"first","affiliation":[{"name":"Departments of Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Gyoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Departments of Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Chang","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Harris","sequence":"additional","affiliation":[{"name":"Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu","family":"Reddy","sequence":"additional","affiliation":[{"name":"Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Klug","sequence":"additional","affiliation":[{"name":"Departments of Microbiology,"},{"name":"Biochemistry and Molecular Genetics,"},{"name":"Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111808350748500_B1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0959-437X(02)00018-7","article-title":"The core-binding factor leukemias: lessons learned from murine models.","volume":"13","author":"Downing","year":"2003","journal-title":"Curr Opin Genet Dev"},{"issue":"5340","key":"2019111808350748500_B2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.278.5340.1059","article-title":"Oncogenic transcription factors in the human acute leukemias.","volume":"278","author":"Look","year":"1997","journal-title":"Science"},{"issue":"7","key":"2019111808350748500_B3","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood.V80.7.1825.1825","article-title":"Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1\/ETO, with similarity to Drosophila segmentation gene, runt.","volume":"80","author":"Erickson","year":"1992","journal-title":"Blood"},{"issue":"23","key":"2019111808350748500_B4","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1073\/pnas.88.23.10431","article-title":"t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.","volume":"88","author":"Miyoshi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2019111808350748500_B5","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex.","volume":"95","author":"Wang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2019111808350748500_B6","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/MCB.21.19.6470-6483.2001","article-title":"ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.","volume":"21","author":"Amann","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2019111808350748500_B7","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","article-title":"ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.","volume":"18","author":"Lutterbach","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2019111808350748500_B8","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","article-title":"Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.","volume":"18","author":"Gelmetti","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2019111808350748500_B9","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V91.9.3134","article-title":"Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.","volume":"91","author":"Okuda","year":"1998","journal-title":"Blood"},{"issue":"8","key":"2019111808350748500_B10","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808350748500_B11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"issue":"3","key":"2019111808350748500_B12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0397-303","article-title":"Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.","volume":"15","author":"Yergeau","year":"1997","journal-title":"Nat Genet"},{"issue":"10","key":"2019111808350748500_B13","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood.V99.10.3801","article-title":"In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.","volume":"99","author":"Wiemels","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111808350748500_B14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","article-title":"Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.","volume":"1","author":"Higuchi","year":"2002","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111808350748500_B15","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood.V96.6.2108","article-title":"Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.","volume":"96","author":"Rhoades","year":"2000","journal-title":"Blood"},{"issue":"15","key":"2019111808350748500_B16","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1128\/MCB.22.15.5506-5517.2002","article-title":"Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.","volume":"22","author":"de Guzman","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019111808350748500_B17","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1182\/blood.V87.11.4789.bloodjournal87114789","article-title":"Persistence of multipotent progenitors expressing AML1\/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.","volume":"87","author":"Miyamoto","year":"1996","journal-title":"Blood"},{"issue":"44","key":"2019111808350748500_B18","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/onc.2008.196","article-title":"Complementing mutations in core binding factor leukemias: from mouse models to clinical applications.","volume":"27","author":"Muller","year":"2008","journal-title":"Oncogene"},{"issue":"16","key":"2019111808350748500_B19","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1073\/pnas.1531730100","article-title":"An activated receptor tyrosine kinase, TEL\/PDGFbetaR, cooperates with AML1\/ETO to induce acute myeloid leukemia in mice.","volume":"100","author":"Grisolano","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111808350748500_B20","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1172\/JCI24225","article-title":"The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.","volume":"115","author":"Schessl","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"2019111808350748500_B21","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2005-04-1656","article-title":"AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.","volume":"107","author":"Nishida","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111808350748500_B22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.20020824","article-title":"AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency.","volume":"196","author":"Schwieger","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"2019111808350748500_B23","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1182\/blood-2006-03-012575","article-title":"The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.","volume":"109","author":"Peterson","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111808350748500_B24","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111808350748500_B25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1999.01449.x","article-title":"c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.","volume":"105","author":"Gari","year":"1999","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808350748500_B26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"C-kit mutations in core binding factor leukemias.","volume":"95","author":"Beghini","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2019111808350748500_B27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.","volume":"121","author":"Care","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808350748500_B28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2402795","article-title":"C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index.","volume":"17","author":"Cairoli","year":"2003","journal-title":"Leukemia"},{"issue":"8","key":"2019111808350748500_B29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.leu.2403803","article-title":"Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).","volume":"19","author":"Nanri","year":"2005","journal-title":"Leukemia"},{"issue":"4","key":"2019111808350748500_B30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and C-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808350748500_B31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2141.2006.06229.x","article-title":"Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)\/AML1-ETO.","volume":"134","author":"Kuchenbauer","year":"2006","journal-title":"Br J Haematol"},{"issue":"24","key":"2019111808350748500_B32","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111808350748500_B33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"2019111808350748500_B34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbrc.2005.09.150","article-title":"Structure and regulation of Kit protein-tyrosine kinase: the stem cell factor receptor.","volume":"338","author":"Roskoski","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2019111808350748500_B35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/stemcells.2004-0117","article-title":"Normal and oncogenic forms of the receptor tyrosine kinase kit.","volume":"23","author":"Lennartsson","year":"2005","journal-title":"Stem Cells"},{"issue":"9","key":"2019111808350748500_B36","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","article-title":"Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.","volume":"107","author":"Cairoli","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019111808350748500_B37","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1073\/pnas.1019625108","article-title":"C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111808350748500_B38","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","article-title":"KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.","volume":"105","author":"Kohl","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111808350748500_B39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood"},{"issue":"1","key":"2019111808350748500_B40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/MCB.01153-06","article-title":"Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.","volume":"27","author":"Xiang","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"16","key":"2019111808350748500_B41","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1073\/pnas.93.16.8508","article-title":"Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins.","volume":"93","author":"Anderson","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2019111808350748500_B42","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1182\/blood-2002-10-3139","article-title":"Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.","volume":"101","author":"Cotta","year":"2003","journal-title":"Blood"},{"issue":"3","key":"2019111808350748500_B43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood"},{"issue":"18","key":"2019111808350748500_B44","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1073\/pnas.171321298","article-title":"AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.","volume":"98","author":"Yuan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111808350748500_B45","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood-2005-02-0583","article-title":"Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate.","volume":"106","author":"Cammenga","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111808350748500_B46","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111808350748500_B47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-2141.2009.08035.x","article-title":"KIT mutations confer a distinct gene expression signature in core binding factor leukaemia.","volume":"148","author":"Luck","year":"2010","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111808350748500_B48","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1541-7786.MCR-09-0138","article-title":"The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment.","volume":"7","author":"Bougherara","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"7","key":"2019111808350748500_B49","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1074\/jbc.271.7.3347","article-title":"Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase.","volume":"271","author":"Moriyama","year":"1996","journal-title":"J Biol Chem"},{"issue":"13","key":"2019111808350748500_B50","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1073\/pnas.97.13.7521","article-title":"AML1\/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.","volume":"97","author":"Miyamoto","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/6\/1522\/1356997\/zh800612001522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/6\/1522\/1356997\/zh800612001522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:58:48Z","timestamp":1574085528000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/6\/1522\/30168\/Distinct-classes-of-cKitactivating-mutations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,9]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-338228","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,9]]}}}